MoneyWorks4Me

Cipla informs about schedule of investor meet

26 Jun 2021 Evaluate

Pursuant to Regulation 30 of the Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015, Cipla has informed that it enclosed the schedule of Analyst/ Institutional Investor Meeting with the Company.

The above information is a part of company’s filings submitted to BSE.

Peers
Company Name CMP
Sun Pharma. Inds. 1753.50
Dr. Reddys Labs. 1235.35
Cipla 1330.00
Lupin 1960.00
Zydus Lifesciences 1123.55
View more..